查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1768463

ELISpot 和 FluoroSpot 检测的全球市场

ELISpot and FluoroSpot Assay
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 267 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年，ELISpot 和 FluoroSpot 检测的全球市场规模将达到 10 亿美元

2024年，全球酵素连结免疫吸附试验（ELISpot）和萤光蛋白检测（FluoroSpot）市场规模估计为4.32亿美元，预计到2030年将达到10亿美元，2024年至2030年的复合年增长率为15.1%。检测套件是本报告分析的细分市场之一，预计其复合年增长率为15.3%，到分析期结束时市场规模将达到4.644亿美元。分析仪器细分市场在分析期间内的复合年增长率估计为15.3%。

美国市场规模估计为 1.092 亿美元，中国市场预计复合年增长率为 19.6%

预计到2024年，美国的酵素连结免疫吸附试验（ELISpot）和萤光蛋白检测（FluoroSpot）市场规模将达到1.092亿美元。预计到2030年，作为世界第二大经济体的中国市场规模将达到2.564亿美元，在2024-2030年的分析期内，复合年增长率为19.6%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为10.0%和12.6%。在欧洲，预计德国市场的复合年增长率为11.1%。

全球 ELISpot 和 FluoroSpot 检测市场—主要趋势和驱动因素摘要

为什么 ELISpot 和 FluoroSpot 检测对于免疫学研究至关重要？

ELISpot（酵素连结免疫斑点法）和 FluoroSpot 检测是免疫学研究中的重要工具，广泛用于在单细胞层级检测和量化免疫反应。这些检测专门用于测量单一细胞分泌的细胞激素、趋化素和其他免疫分子，使研究人员能够以高灵敏度和特异性分析细胞介导的免疫反应。 ELISpot 主要用于识别分泌一种分子的细胞，而 FluoroSpot 具有多重功能，可同时检测多种细胞激素，这使其在复杂的免疫学研究中非常有用。这两种检测对于疫苗开发、感染疾病研究、自体免疫研究和癌症免疫疗法都至关重要，可为了解免疫机制和治疗效果提供基础。

ELISpot 和 FluoroSpot 检测法能够检测稀有免疫细胞和细微免疫反应，是研究细胞介导免疫的理想选择，特别适用于细胞介导反应发挥关键作用的疾病。在临床试验中，这些检测法用于评估疫苗的免疫抗原性并监测免疫疗法中的免疫反应。随着对精准单细胞免疫分析的需求日益增长，ELISpot 和 FluoroSpot 检测法对于免疫学、疫苗研发和个人化医疗的进步至关重要。

技术进步如何改变 ELISpot 和 FluoroSpot 侦测市场？

ELISpot 和 FluoroSpot 检测的技术进步提高了检测灵敏度、通量和数据分析能力，使其能够更有效地进行复杂的免疫分析。其中最重要的进展之一是 FluoroSpot 检测的多重检测功能，该功能可在同一孔中同时检测多个免疫标记。此功能使研究人员能够更全面地了解免疫细胞反应，这在癌症和自体免疫疾病等复杂疾病中尤其有用。多重检测减少了所需的样本量，提高了检测效率，使研究人员能够从有限的样本中收集更多数据。

ELISpot 和 FluoroSpot 检测工作流程的自动化也是一项关键进步，它提高了检测通量并减少了手动操作时间。自动化盘式分析仪和分析软体提供高解析度成像和定量数据，确保结果准确且可重复，同时最大限度地减少人为错误。此外，萤光染料稳定性和影像分析软体的改进增强了 FluoroSpot 检测的性能，使其能够进行更可靠的多重检测和快速的数据解读。这些进步使 ELISpot 和 FluoroSpot 检测更易于获取、更易于扩展，并更适用于高复杂性的免疫学研究，从而拓展了其在科学研究和临床环境中的应用。

ELISpot 和 FluoroSpot 侦测的主要应用是什么？

ELISpot 和 FluoroSpot 检测广泛应用于免疫学领域，包括感染疾病研究、疫苗研发、癌症免疫学和自体免疫疾病研究。在感染疾病研究中，这些检测有助于检测和量化病原体特异性T 细胞反应，使研究人员能够评估针对 HIV、结核病和流感等疾病的免疫保护程度。 ELISpot 广泛应用于疫苗研发，透过检测抗原特异性T 细胞和其他免疫细胞的频率来衡量疫苗效力，有助于确定免疫抗原性和免疫持续时间。

在癌症免疫学中，FluoroSpot 检测技术透过检测 T 细胞的细胞激素分泌谱来表征肿瘤特异性免疫反应，使研究人员能够分析免疫系统对癌症的反应并评估免疫疗法的疗效。在自体免疫疾病中，这些检测技术透过检测发炎细胞激素来深入了解异常免疫反应，并有助于识别免疫失调的机制。此外，在移植研究中，ELISpot 和 FluoroSpot 检测技术可以帮助评估捐赠者特异性免疫反应并预测移植排斥的风险。这些应用凸显了 ELISpot 和 FluoroSpot 检测技术的多功能性，可提供高解析度的免疫谱分析，从而支持疗法研发和免疫疗法的进步。

是什么推动了 ELISpot 和 FluoroSpot 检测市场的成长？

ELISpot 和 FluoroSpot 检测市场的成长得益于对灵敏免疫监测工具日益增长的需求、免疫疗法和疫苗研究的进步以及多重检测和自动化技术的创新。这些检测能够精准监测免疫反应，支持开发针对性和个人化的治疗方法，从而推动了癌症免疫疗法和标靶治疗化医疗领域的不断发展。感染疾病研究的不断深入，尤其是针对新兴病原体和疫苗研发的研究，也推动了对 ELISpot 和 FluoroSpot 检测的需求，这些检测为免疫防御和疫苗有效性提供了关键的见解。

多重检测和自动化数据分析技术的进步使这些检测更加高效、便捷，从而促进了它们在高通量研究环境中的应用。自动化成像和数据分析系统的整合提高了检测的可重复性和通量，使其适用于大规模临床试验和诊断应用。此外，对能够进行全面免疫分析的工具的需求，也推动了学术机构、製药公司和企业委託研究组织 (CRO) 对免疫研究工具的需求。

部分

产品（检测试剂套件、分析设备、辅助产品）；应用（诊断、研究）

受访公司范例

  • Abcam
  • Autoimmun Diagnostika GmbH
  • Becton, Dickinson and Company
  • Biotech Investissement Group
  • Bio-Techne
  • Cellular Technology Limited（CTL）
  • Lophius Biosciences GmbH
  • Mabtech AB
  • Oxford Immunotec
  • U-Cytech Biosciences

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP21716

Global ELISpot and FluoroSpot Assay Market to Reach US$1.0 Billion by 2030

The global market for ELISpot and FluoroSpot Assay estimated at US$432.0 Million in the year 2024, is expected to reach US$1.0 Billion by 2030, growing at a CAGR of 15.1% over the analysis period 2024-2030. Assay Kits, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$464.4 Million by the end of the analysis period. Growth in the Analyzers segment is estimated at 15.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$109.2 Million While China is Forecast to Grow at 19.6% CAGR

The ELISpot and FluoroSpot Assay market in the U.S. is estimated at US$109.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$256.4 Million by the year 2030 trailing a CAGR of 19.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.0% and 12.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.1% CAGR.

Global ELISpot and FluoroSpot Assay Market - Key Trends & Drivers Summarized

Why Are ELISpot and FluoroSpot Assays Essential in Immunological Research?

ELISpot (Enzyme-Linked ImmunoSpot) and FluoroSpot assays are crucial tools in immunological research, widely used for detecting and quantifying immune responses at the single-cell level. These assays are specifically designed to measure the secretion of cytokines, chemokines, or other immune molecules from individual cells, allowing researchers to analyze cell-mediated immune responses with high sensitivity and specificity. ELISpot is used primarily to identify cells secreting a single type of molecule, while FluoroSpot, with its multiplexing capability, can detect multiple cytokines simultaneously, making it invaluable in complex immunological studies. Both assays are essential in vaccine development, infectious disease research, autoimmune studies, and cancer immunotherapy, providing insights into immune mechanisms and treatment efficacy.

The ability of ELISpot and FluoroSpot assays to detect rare immune cells and subtle immune responses makes them ideal for studying cellular immunity, particularly in diseases where cell-mediated responses play a critical role. In clinical trials, these assays are used to evaluate the immunogenicity of vaccines and monitor immune responses in immunotherapy treatments. As the demand for precise, single-cell immune analysis grows, ELISpot and FluoroSpot assays continue to be essential in advancing immunology, vaccine development, and personalized medicine.

How Are Technological Advancements Transforming the ELISpot and FluoroSpot Assay Market?

Technological advancements in ELISpot and FluoroSpot assays are enhancing assay sensitivity, throughput, and data analysis, making them more effective for complex immune profiling. One of the most significant developments is in multiplexing capabilities in FluoroSpot assays, which allow for simultaneous detection of multiple immune markers within the same well. This capability provides researchers with a more comprehensive view of immune cell responses, especially valuable in complex diseases such as cancer and autoimmune disorders. Multiplexing reduces the sample volume required and improves assay efficiency, enabling researchers to gather more data from limited samples.

Automation in ELISpot and FluoroSpot assay workflows is another critical advancement, increasing assay throughput and reducing hands-on time, which is especially beneficial in large-scale studies and clinical trials. Automated plate readers and analysis software provide high-resolution imaging and quantitative data, ensuring accurate, reproducible results while minimizing human error. Additionally, improvements in fluorescent dye stability and image analysis software are enhancing FluoroSpot assays, allowing for more reliable multiplex detection and faster data interpretation. Together, these advancements are making ELISpot and FluoroSpot assays more accessible, scalable, and suitable for high-complexity immune studies, expanding their application across research and clinical settings.

What Are the Key Applications of ELISpot and FluoroSpot Assays?

ELISpot and FluoroSpot assays are used across a wide range of immunological applications, including infectious disease research, vaccine development, cancer immunology, and autoimmune disease studies. In infectious disease research, these assays are instrumental in detecting and quantifying pathogen-specific T cell responses, allowing researchers to evaluate immune protection levels against diseases like HIV, tuberculosis, and influenza. ELISpot is widely used in vaccine development, where it helps measure vaccine efficacy by detecting the frequency of antigen-specific T cells and other immune cells, supporting the identification of immunogenicity and duration of immunity.

In cancer immunology, FluoroSpot assays are used to characterize tumor-specific immune responses by detecting cytokine secretion profiles of T cells, enabling researchers to analyze the immune system's response to cancer and evaluate the effectiveness of immunotherapies. For autoimmune diseases, these assays provide insights into aberrant immune responses by detecting pro-inflammatory cytokines, aiding in the identification of immune dysregulation mechanisms. Additionally, in transplantation research, ELISpot and FluoroSpot assays assess donor-specific immune responses, helping to predict transplant rejection risk. These applications underscore the versatility of ELISpot and FluoroSpot assays in providing high-resolution immune profiling, supporting advancements in treatment development and immunotherapy.

What Is Driving Growth in the ELISpot and FluoroSpot Assay Market?

The growth in the ELISpot and FluoroSpot assay market is driven by increasing demand for high-sensitivity immune monitoring tools, advancements in immunotherapy and vaccine research, and technological innovations in multiplexing and automation. The expanding fields of cancer immunotherapy and personalized medicine are major drivers, as these assays enable precise monitoring of immune responses, supporting the development of targeted therapies and individualized treatment approaches. The rise in infectious disease research, particularly in response to emerging pathogens and vaccine development, is also boosting demand for ELISpot and FluoroSpot assays, which provide critical insights into immune protection and vaccine efficacy.

Technological advancements in multiplex detection and automated data analysis are making these assays more efficient and accessible, encouraging their adoption in high-throughput research environments. The integration of automated imaging and data analysis systems has increased assay reproducibility and throughput, making them suitable for large-scale clinical trials and diagnostic applications. Additionally, the demand for immunological research tools in academia, pharmaceutical companies, and contract research organizations (CROs) is growing, driven by the need for tools that enable comprehensive immune profiling.

SCOPE OF STUDY:

The report analyzes the ELISpot and FluoroSpot Assay market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Assay Kits, Analyzers, Ancillary Products); Application (Diagnostic, Research)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 33 Featured) -

  • Abcam
  • Autoimmun Diagnostika GmbH
  • Becton, Dickinson and Company
  • Biotech Investissement Group
  • Bio-Techne
  • Cellular Technology Limited (CTL)
  • Lophius Biosciences GmbH
  • Mabtech AB
  • Oxford Immunotec
  • U-Cytech Biosciences

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • ELISpot and FluoroSpot Assay - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Demand for Immune Monitoring Drives Growth in ELISpot and FluoroSpot Assay Markets for Immunological Research
    • Rising Focus on Infectious Disease Research Expands Market for ELISpot and FluoroSpot in Vaccine Development
    • Technological Advancements in Multiplexing Capabilities Propel Growth of FluoroSpot Assay for Multi-Cytokine Detection
    • Growth of Cancer Immunotherapy Research Boosts Demand for ELISpot Assays in T-Cell and B-Cell Response Analysis
    • Increasing Adoption of FluoroSpot Assays in Autoimmune Disease Studies Expands Market for Precise Immune Profiling
    • Focus on Precision Medicine Drives Demand for Highly Sensitive Assays in Personalized Immunotherapy Development
    • Expansion of Academic and Clinical Research Institutions Strengthens Demand for ELISpot and FluoroSpot Assays in Immunology
    • Increasing Interest in Cellular Immune Response Analysis Propels Market for Assays with High Throughput Capabilities
    • Advances in Imaging and Detection Technology Enhance Reliability and Sensitivity of ELISpot and FluoroSpot Assays
    • Rising Demand for High-Throughput Screening in Drug Development Expands Market for Automated ELISpot Platforms
    • Focus on Reducing False Positives in Immunoassays Drives Innovation in FluoroSpot for Enhanced Specificity
    • Increasing Use of FluoroSpot Assays in Allergy Research Boosts Demand for Multiplex Analysis of Allergen Responses
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for ELISpot and FluoroSpot Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for ELISpot and FluoroSpot Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Assay Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Assay Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Assay Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Ancillary Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Ancillary Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Ancillary Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Diagnostic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World ELISpot and FluoroSpot Assay Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • ELISpot and FluoroSpot Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for ELISpot and FluoroSpot Assay by Product - Percentage Breakdown of Value Sales for Assay Kits, Analyzers and Ancillary Products for the Years 2015, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for ELISpot and FluoroSpot Assay by Application - Percentage Breakdown of Value Sales for Diagnostic and Research for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for ELISpot and FluoroSpot Assay by Product - Percentage Breakdown of Value Sales for Assay Kits, Analyzers and Ancillary Products for the Years 2015, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for ELISpot and FluoroSpot Assay by Application - Percentage Breakdown of Value Sales for Diagnostic and Research for the Years 2015, 2025 & 2030
  • JAPAN
    • ELISpot and FluoroSpot Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for ELISpot and FluoroSpot Assay by Product - Percentage Breakdown of Value Sales for Assay Kits, Analyzers and Ancillary Products for the Years 2015, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for ELISpot and FluoroSpot Assay by Application - Percentage Breakdown of Value Sales for Diagnostic and Research for the Years 2015, 2025 & 2030
  • CHINA
    • ELISpot and FluoroSpot Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for ELISpot and FluoroSpot Assay by Product - Percentage Breakdown of Value Sales for Assay Kits, Analyzers and Ancillary Products for the Years 2015, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for ELISpot and FluoroSpot Assay by Application - Percentage Breakdown of Value Sales for Diagnostic and Research for the Years 2015, 2025 & 2030
  • EUROPE
    • ELISpot and FluoroSpot Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for ELISpot and FluoroSpot Assay by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for ELISpot and FluoroSpot Assay by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for ELISpot and FluoroSpot Assay by Product - Percentage Breakdown of Value Sales for Assay Kits, Analyzers and Ancillary Products for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for ELISpot and FluoroSpot Assay by Application - Percentage Breakdown of Value Sales for Diagnostic and Research for the Years 2015, 2025 & 2030
  • FRANCE
    • ELISpot and FluoroSpot Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for ELISpot and FluoroSpot Assay by Product - Percentage Breakdown of Value Sales for Assay Kits, Analyzers and Ancillary Products for the Years 2015, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for ELISpot and FluoroSpot Assay by Application - Percentage Breakdown of Value Sales for Diagnostic and Research for the Years 2015, 2025 & 2030
  • GERMANY
    • ELISpot and FluoroSpot Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for ELISpot and FluoroSpot Assay by Product - Percentage Breakdown of Value Sales for Assay Kits, Analyzers and Ancillary Products for the Years 2015, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for ELISpot and FluoroSpot Assay by Application - Percentage Breakdown of Value Sales for Diagnostic and Research for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for ELISpot and FluoroSpot Assay by Product - Percentage Breakdown of Value Sales for Assay Kits, Analyzers and Ancillary Products for the Years 2015, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for ELISpot and FluoroSpot Assay by Application - Percentage Breakdown of Value Sales for Diagnostic and Research for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • ELISpot and FluoroSpot Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for ELISpot and FluoroSpot Assay by Product - Percentage Breakdown of Value Sales for Assay Kits, Analyzers and Ancillary Products for the Years 2015, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for ELISpot and FluoroSpot Assay by Application - Percentage Breakdown of Value Sales for Diagnostic and Research for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for ELISpot and FluoroSpot Assay by Product - Percentage Breakdown of Value Sales for Assay Kits, Analyzers and Ancillary Products for the Years 2015, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for ELISpot and FluoroSpot Assay by Application - Percentage Breakdown of Value Sales for Diagnostic and Research for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for ELISpot and FluoroSpot Assay by Product - Percentage Breakdown of Value Sales for Assay Kits, Analyzers and Ancillary Products for the Years 2015, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for ELISpot and FluoroSpot Assay by Application - Percentage Breakdown of Value Sales for Diagnostic and Research for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for ELISpot and FluoroSpot Assay by Product - Percentage Breakdown of Value Sales for Assay Kits, Analyzers and Ancillary Products for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for ELISpot and FluoroSpot Assay by Application - Percentage Breakdown of Value Sales for Diagnostic and Research for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • ELISpot and FluoroSpot Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for ELISpot and FluoroSpot Assay by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for ELISpot and FluoroSpot Assay by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for ELISpot and FluoroSpot Assay by Product - Percentage Breakdown of Value Sales for Assay Kits, Analyzers and Ancillary Products for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for ELISpot and FluoroSpot Assay by Application - Percentage Breakdown of Value Sales for Diagnostic and Research for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • ELISpot and FluoroSpot Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for ELISpot and FluoroSpot Assay by Product - Percentage Breakdown of Value Sales for Assay Kits, Analyzers and Ancillary Products for the Years 2015, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for ELISpot and FluoroSpot Assay by Application - Percentage Breakdown of Value Sales for Diagnostic and Research for the Years 2015, 2025 & 2030
  • INDIA
    • ELISpot and FluoroSpot Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for ELISpot and FluoroSpot Assay by Product - Percentage Breakdown of Value Sales for Assay Kits, Analyzers and Ancillary Products for the Years 2015, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for ELISpot and FluoroSpot Assay by Application - Percentage Breakdown of Value Sales for Diagnostic and Research for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for ELISpot and FluoroSpot Assay by Product - Percentage Breakdown of Value Sales for Assay Kits, Analyzers and Ancillary Products for the Years 2015, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for ELISpot and FluoroSpot Assay by Application - Percentage Breakdown of Value Sales for Diagnostic and Research for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for ELISpot and FluoroSpot Assay by Product - Percentage Breakdown of Value Sales for Assay Kits, Analyzers and Ancillary Products for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for ELISpot and FluoroSpot Assay by Application - Percentage Breakdown of Value Sales for Diagnostic and Research for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • ELISpot and FluoroSpot Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for ELISpot and FluoroSpot Assay by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for ELISpot and FluoroSpot Assay by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for ELISpot and FluoroSpot Assay by Product - Percentage Breakdown of Value Sales for Assay Kits, Analyzers and Ancillary Products for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for ELISpot and FluoroSpot Assay by Application - Percentage Breakdown of Value Sales for Diagnostic and Research for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for ELISpot and FluoroSpot Assay by Product - Percentage Breakdown of Value Sales for Assay Kits, Analyzers and Ancillary Products for the Years 2015, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for ELISpot and FluoroSpot Assay by Application - Percentage Breakdown of Value Sales for Diagnostic and Research for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for ELISpot and FluoroSpot Assay by Product - Percentage Breakdown of Value Sales for Assay Kits, Analyzers and Ancillary Products for the Years 2015, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for ELISpot and FluoroSpot Assay by Application - Percentage Breakdown of Value Sales for Diagnostic and Research for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for ELISpot and FluoroSpot Assay by Product - Percentage Breakdown of Value Sales for Assay Kits, Analyzers and Ancillary Products for the Years 2015, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for ELISpot and FluoroSpot Assay by Application - Percentage Breakdown of Value Sales for Diagnostic and Research for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for ELISpot and FluoroSpot Assay by Product - Percentage Breakdown of Value Sales for Assay Kits, Analyzers and Ancillary Products for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for ELISpot and FluoroSpot Assay by Application - Percentage Breakdown of Value Sales for Diagnostic and Research for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • ELISpot and FluoroSpot Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for ELISpot and FluoroSpot Assay by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for ELISpot and FluoroSpot Assay by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for ELISpot and FluoroSpot Assay by Product - Percentage Breakdown of Value Sales for Assay Kits, Analyzers and Ancillary Products for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for ELISpot and FluoroSpot Assay by Application - Percentage Breakdown of Value Sales for Diagnostic and Research for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for ELISpot and FluoroSpot Assay by Product - Percentage Breakdown of Value Sales for Assay Kits, Analyzers and Ancillary Products for the Years 2015, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for ELISpot and FluoroSpot Assay by Application - Percentage Breakdown of Value Sales for Diagnostic and Research for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for ELISpot and FluoroSpot Assay by Product - Percentage Breakdown of Value Sales for Assay Kits, Analyzers and Ancillary Products for the Years 2015, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for ELISpot and FluoroSpot Assay by Application - Percentage Breakdown of Value Sales for Diagnostic and Research for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for ELISpot and FluoroSpot Assay by Product - Percentage Breakdown of Value Sales for Assay Kits, Analyzers and Ancillary Products for the Years 2015, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for ELISpot and FluoroSpot Assay by Application - Percentage Breakdown of Value Sales for Diagnostic and Research for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for ELISpot and FluoroSpot Assay by Product - Percentage Breakdown of Value Sales for Assay Kits, Analyzers and Ancillary Products for the Years 2015, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for ELISpot and FluoroSpot Assay by Application - Percentage Breakdown of Value Sales for Diagnostic and Research for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for ELISpot and FluoroSpot Assay by Product - Percentage Breakdown of Value Sales for Assay Kits, Analyzers and Ancillary Products for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for ELISpot and FluoroSpot Assay by Application - Percentage Breakdown of Value Sales for Diagnostic and Research for the Years 2015, 2025 & 2030
  • AFRICA
    • ELISpot and FluoroSpot Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for ELISpot and FluoroSpot Assay by Product - Assay Kits, Analyzers and Ancillary Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for ELISpot and FluoroSpot Assay by Product - Percentage Breakdown of Value Sales for Assay Kits, Analyzers and Ancillary Products for the Years 2015, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for ELISpot and FluoroSpot Assay by Application - Diagnostic and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for ELISpot and FluoroSpot Assay by Application - Percentage Breakdown of Value Sales for Diagnostic and Research for the Years 2015, 2025 & 2030

IV. COMPETITION